ModuleMD Achieves Impressive Rank on the 2025 Inc. 5000 List Celebrating Growth and Innovation

ModuleMD's Remarkable Achievement on the 2025 Inc. 5000 List

In a remarkable feat, ModuleMD has secured the 585th position on the esteemed 2025 Inc. 5000 list, recognizing the fastest-growing private companies in the United States. This announcement, made by Inc. magazine—a leading source for business news and entrepreneurial insights—highlights the exceptional growth trajectory of ModuleMD in a challenging economic environment.

Founded with the mission to revolutionize the healthcare sector, ModuleMD specializes in electronic health record (EHR) solutions tailored for Allergy, Pulmonology, and ENT practices. Under the leadership of CEO Abhinay Rao, the company’s success is rooted in its commitment to reducing clinician burnout, simplifying care delivery, and enhancing the overall joy of practicing medicine. Rao emphasizes that every innovation originates from genuine discussions with healthcare practitioners, underscoring a deep understanding of their everyday challenges.

This year's Inc. 5000 cohort has demonstrated remarkable resilience, navigating uncertainties such as economic fluctuations and labor market changes while achieving an impressive median three-year revenue growth rate of 1,552%. Collectively, these honorees have contributed over 48,678 new jobs to the economy.

Mike Hofman, editor-in-chief of Inc., stated, "Making the Inc. 5000 is a significant accomplishment, reflecting the tenacity and vision of these companies. They’ve thrived amid rising costs and global shifts, embodying the entrepreneurial spirit vital to the U.S. economy."

To qualify for the Inc. 5000, companies must meet specific criteria, including being U.S.-based, privately held, and independent, alongside achieving significant revenue milestones. For ModuleMD, being included in this prestigious list marks not only a rewarding milestone but also aligns with the company's celebration of 25 years of innovation in specialty healthcare. This year, the company is particularly proud of unveiling the latest iterations of its AI-driven solutions at the AAAAI Annual Meeting.

Looking ahead, ModuleMD will showcase its comprehensive offerings later this year at ACAAI 2025. The full suite of solutions is set to demonstrate how the company’s intelligent platforms enhance workflows, improve reimbursements, and alleviate provider fatigue. These advancements are tailored to meet the labor demands of healthcare professionals, thus driving the mission of quality patient care.

ModuleMD's key solutions include the Unified EHR PM platform for efficient documentation and scheduling, RCM Services for maximizing reimbursements, and several specialized tools designed to support allergy management and infusion tracking. The company's AI innovations, such as the JOSH multilingual dictation tool and SPOCK front office automation, highlight a forward-thinking approach to address the intricacies of modern healthcare practice.

Recognized as a G2 High Performer from 2022 to 2025 and acknowledged as a Top 100 Healthcare Technology Company in 2023, ModuleMD's impact in the realm of specialty care underscores its commitment to innovation and excellence. With its headquarters based in Grand Blanc, Michigan, the company is redefining healthcare technology, promising streamlined processes, enhanced compliance, and improved patient outcomes.

For more insights into ModuleMD's offerings or to learn more about their journey, visit www.modulemd.com.